HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C*12:02/C*14:03

被引:26
作者
Lin, Zhansong [1 ]
Kuroki, Kimiko [2 ]
Kuse, Nozomi [1 ]
Sun, Xiaoming [1 ]
Akahoshi, Tomohiro [1 ]
Qi, Ying [3 ]
Chikata, Takayuki [1 ]
Naruto, Takuya [1 ]
Koyanagi, Madoka [1 ]
Murakoshi, Hayato [1 ]
Gatanaga, Hiroyuki [1 ,6 ]
Oka, Shinichi [1 ,6 ]
Carrington, Mary [3 ,4 ,5 ]
Maenaka, Katsumi [2 ]
Takiguchi, Masafumi [1 ]
机构
[1] Kumamoto Univ, Ctr AIDS Res, Chuo Ku, Kumamoto 8600811, Japan
[2] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomol Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan
[3] Leidos Biomed Res Inc, Frederick Natl Labs Canc Res, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21701 USA
[4] MIT, MGH, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[5] Harvard, Cambridge, MA 02139 USA
[6] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Shinjuku Ku, Tokyo 1628655, Japan
来源
CELL REPORTS | 2016年 / 17卷 / 09期
关键词
MHC CLASS-I; NATURAL-KILLER-CELLS; CD8(+) T-CELLS; HLA-C; INHIBITORY RECEPTORS; JAPANESE POPULATION; DOWN-REGULATION; VIRUS-INFECTION; SUBTYPE B; BINDING;
D O I
10.1016/j.celrep.2016.10.075
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Natural killer (NK) cells control viral infection in part through the interaction between killer cell immunoglobulin-like receptors (KIRs) and their human leukocyte antigen (HLA) ligands. We investigated 504 anti-retroviral (ART)-free Japanese patients chronically infected with HIV-1 and identified two KIR/HLA combinations, KIR2DL2/HLA-C*12:02 and KIR2DL2/HLA-C*14:03, that impact suppression of HIV-1 replication. KIR2DL2(+) NK cells suppressed viral replication in HLA-C*14:03(+) or HLA-C*12:02(+) cells to a significantly greater extent than did KIR2DL2(-) NK cells in vitro. Functional analysis showed that the binding between HIV-1-derived peptide and HLA-C*14:03 or HLA-C*12:02 influenced KIR2DL2(+) NK cell activity through reduced expression of the peptide-HLA (pHLA) complex on the cell surface (i.e., reduced KIR2DL2 ligand expression), rather than through reduced binding affinity of KIR2DL2 to the respective pHLA complexes. Thus, KIR2DL2/HLA-C*12:02 and KIR2DL2/HLA-C*14:03 compound genotypes have protective effects on control of HIV-1 through a mechanism involving KIR2DL2-mediated NK cell recognition of virusinfected cells, providing additional understanding of NK cells in HIV-1 infection.
引用
收藏
页码:2210 / 2220
页数:11
相关论文
共 38 条
  • [21] Single Nucleotide Polymorphism in KIR2DL1 Is Associated With HLA-C Expression in Global Populations
    Vargas, Luciana de Brito
    Dourado, Renata M.
    Amorim, Leonardo M.
    Ho, Brenda
    Calonga-Solis, Veronica
    Issler, Hellen C.
    Marin, Wesley M.
    Beltrame, Marcia H.
    Petzl-Erler, Maria Luiza
    Hollenbach, Jill A.
    Augusto, Danillo G.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [22] KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population
    Wisniewski, Andrzej
    Jankowska, Renata
    Passowicz-Muszynska, Ewa
    Wisniewska, Elzbieta
    Majorczyk, Edyta
    Nowak, Izabela
    Frydecka, Irena
    Kusnierczyk, Piotr
    HUMAN IMMUNOLOGY, 2012, 73 (09) : 927 - 931
  • [23] T cells discriminate between groups C1 and C2 HLA-C
    Sim, Malcolm J. W.
    Stotz, Zachary
    Lu, Jinghua
    Brennan, Paul
    Long, Eric O.
    Sun, Peter D.
    ELIFE, 2022, 11
  • [24] The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation
    Zuo, Wei
    Yu, Xing-Xing
    Liu, Xue-Fei
    Chang, Ying-Jun
    Wang, Yu
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Liu, Kai-Yan
    Zhao, Xiao-Su
    Huang, Xiao-Jun
    Zhao, Xiang-Yu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [25] Identification of a Clade-Specific HLA-C*03:02 CTL Epitope GY9 Derived from the HIV-1 p17 Matrix Protein
    Kyobe, Samuel
    Mwesigwa, Savannah
    Nkurunungi, Gyaviira
    Retshabile, Gaone
    Egesa, Moses
    Katagirya, Eric
    Amujal, Marion
    Mlotshwa, Busisiwe C.
    Williams, Lesedi
    Sendagire, Hakim
    Kiragga, Dithan
    Mardon, Graeme
    Matshaba, Mogomotsi
    Hanchard, Neil A.
    Kyosiimire-Lugemwa, Jacqueline
    Robinson, David
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [26] Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia
    Middleton, D.
    Diler, A. S.
    Meenagh, A.
    Sleator, C.
    Gourraud, P. A.
    TISSUE ANTIGENS, 2009, 73 (06): : 553 - 560
  • [27] Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-C
    Hilton, Hugo G.
    Blokhuis, Jeroen H.
    Guethlein, Lisbeth A.
    Norman, Paul J.
    Parham, Peter
    JOURNAL OF IMMUNOLOGY, 2017, 198 (05) : 1961 - 1973
  • [28] Uptake of CCR7 by KIR2DS4+ NK Cells Is Induced upon Recognition of Certain HLA-C Alleles
    Pesce, Silvia
    Carlomagno, Simona
    Moretta, Alessandro
    Sivori, Simona
    Marcenaro, Emanuela
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [29] Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA-C1 ligand binding
    Ramos-Lopez, E.
    Scholten, F.
    Aminkeng, F.
    Wild, C.
    Kalhes, H.
    Seidl, C.
    Tonn, T.
    Van der Auwera, B.
    Badenhoop, K.
    TISSUE ANTIGENS, 2009, 73 (06): : 599 - 603
  • [30] HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2+ NK cells in Lassa virus infection
    Wauquier, Nadia
    Petitdemange, Caroline
    Tarantino, Nadine
    Maucourant, Christopher
    Coomber, Moinya
    Lungay, Victor
    Bangura, James
    Debre, Patrice
    Vieillard, Vincent
    EBIOMEDICINE, 2019, 40 : 605 - 613